# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3536139 | Functional | Cytotoxicity against human MDA-MB-361 cells assessed as growth inhibition after 3 days by MTS assay | Homo sapiens | 4 | ALA3526043 | cell-based format | Scientific Literature | |
2. | ALA3590989 | Functional | Cytotoxicity against human MDA-MB-361 cells assessed as reduction in cell number incubated for 72 hrs | Homo sapiens | 2 | ALA3588752 | cell-based format | Scientific Literature | |
3. | ALA710682 | Functional | Ratio of the IC50 in thebeta-Gal- and CPG2-expressing cell line | Homo sapiens | 9 | ALA1149165 | cell-based format | Scientific Literature | |
4. | ALA710683 | Functional | Ratio of the IC50 in thebeta-Gal- and CPG2-expressing cell line; no data | Homo sapiens | 1 | ALA1149165 | cell-based format | Scientific Literature | |
5. | ALA707743 | Functional | Cytotoxicity in the line MDA MB 361 breast adenocarcinoma cell line expressing CPG2 | Homo sapiens | 9 | ALA1149165 | cell-based format | Scientific Literature | |
6. | ALA707744 | Functional | Cytotoxicity in the line MDA MB 361 breast adenocarcinoma cell line expressing CPG2; no data | Homo sapiens | 1 | ALA1149165 | cell-based format | Scientific Literature | |
7. | ALA707745 | Functional | Cytotoxicity in the line MDA MB 361 breast adenocarcinoma cell line expressing bata-galactosidase | Homo sapiens | 9 | ALA1149165 | cell-based format | Scientific Literature | |
8. | ALA707746 | Functional | Cytotoxicity in the line MDA MB 361 breast adenocarcinoma cell line expressing bata-galactosidase; no data | Homo sapiens | 1 | ALA1149165 | cell-based format | Scientific Literature | |
9. | ALA707753 | Functional | Inhibition of calcium influx in MDA-361 (breast) tumor cells. | Homo sapiens | 26 | ALA1146797 | cell-based format | Scientific Literature | |
10. | ALA707754 | Functional | Inhibition of cellular proliferation in MDA-361 (breast) tumor cells. | Homo sapiens | 26 | ALA1146797 | cell-based format | Scientific Literature | |
11. | ALA711757 | Functional | The compound was tested for extracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) expressing carboxypeptidase stCPG2. | Homo sapiens | 1 | ALA1132269 | cell-based format | Scientific Literature | |
12. | ALA874167 | Functional | The compound was tested for extracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of stCPG2 prodrug | Homo sapiens | 5 | ALA1132269 | cell-based format | Scientific Literature | |
13. | ALA711758 | Functional | The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) expressing LacZ (beta-galactosidase). | Homo sapiens | 6 | ALA1132269 | cell-based format | Scientific Literature | |
14. | ALA711759 | Functional | The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) expressing carboxypeptidase G2(CPG2). | Homo sapiens | 1 | ALA1132269 | cell-based format | Scientific Literature | |
15. | ALA711760 | Functional | The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of CPG2 prodrug | Homo sapiens | 5 | ALA1132269 | cell-based format | Scientific Literature | |
16. | ALA1068431 | Functional | Growth inhibition of human MDA-MB-361 cells after 72 hrs by celltiter assay | Homo sapiens | 1 | ALA1153170 | cell-based format | Scientific Literature | |
17. | ALA1068074 | Functional | Cytotoxicity against human MDA-MB-361 cells with Her2+/PI3KCA mutant after 72 hrs | Homo sapiens | 25 | ALA1157707 | cell-based format | Scientific Literature | |
18. | ALA1071039 | Functional | Antitumor activity against human MDA-MB-361 cells implanted in mouse assessed as inhibition of regrowth at until day 70 at 100 mg/kg, iv once daily for 5 days | Homo sapiens | 1 | ALA1157707 | organism-based format | Scientific Literature | |
19. | ALA1071040 | Functional | Antitumor activity against human MDA-MB-361 cells implanted in mouse assessed as inhibition of regrowth at until day 16 and 20 at 25 mg/kg, iv once daily for 5 days | Homo sapiens | 1 | ALA1157707 | organism-based format | Scientific Literature | |
20. | ALA1071041 | Functional | Antitumor activity against human MDA-MB-361 cells implanted in mouse assessed as inhibition of regrowth at until day 16 and 20 at 50 mg/kg, iv once daily for 5 days | Homo sapiens | 1 | ALA1157707 | organism-based format | Scientific Literature |